Streetbeat News

LMLLF

Pharmadrug Inc

Industry

Medicinal and Botanical Manufacturing

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

Marijuana stocks experienced significant movement with ESCO Technologies, Global Hemp Group, and others among top gainers, while companies like Aurora Cannabis and OrganiGram Holdings were among the losers. The article highlights the dramatic changes in stock prices for various companies within the marijuana industry, indicating a volatile trading day.

Portfolio Pulse from Benzinga Insights

February 08, 2024 | 9:30 pm

Marijuana stocks experienced significant movements with Affinor Growers, Rhinomed, and others posting major gains, while 1933 Industries, Indiva, and others saw declines. Notably, OrganiGram Holdings, Tilray Brands, Aurora Cannabis, Cronos Group, SNDL, Psychemedics, Village Farms Intl, GrowGeneration, and Genetic Technologies were among the NASDAQ-listed companies with notable changes.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 9:30 pm

The article provides a detailed list of cannabis stock gainers and losers for February 5, 2024, highlighting significant movements in the market. Notable gainers include Tony G Co-Investment and Maple Leaf Green World, with increases of 81.16% and 45.45% respectively. On the losing end, EVIO led with a 99% decrease. Major US-listed companies mentioned include Eastside Distilling, Neptune Wellness Solutions, Village Farms International, Scotts Miracle-Gro, GrowGeneration, Innovative Industrial Properties, Canopy Growth, Tilray Brands, and Urban-gro.

Portfolio Pulse from Benzinga Insights

February 05, 2024 | 9:30 pm

Marijuana stocks experienced significant movements on February 2, 2024, with notable gainers including Tony G Co-Investment, Global Hemp Group, and Khiron Life Sciences. On the downside, Global Compliance, MJ Holdings, and Rocky Mountain High were among the top losers. Neptune Wellness Solutions, Eastside Distilling, Canopy Growth, cbdMD, Corbus Pharmaceuticals, Tilray Brands, and Cronos Group were notable companies listed on major exchanges that saw price changes.

Portfolio Pulse from Benzinga Insights

February 02, 2024 | 9:30 pm

Cannabis stocks experienced significant volatility on January 26, 2024, with Corbus Pharmaceuticals leading the gainers with a 240.88% increase, while Blueberries Medical topped the losers with a 27.49% decline. Other notable movers included SOL Global Investments, C21 Investments, and OrganiGram Holdings with substantial gains, and 1933 Industries, Target Group, and Item 9 Labs with notable losses.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 9:30 pm

On January 23, 2024, several cannabis stocks experienced significant price movements. MedMen Enterprises led the gainers with a 999900.00% increase, closing at $0.01, while Pharmadrug led the losers with a 25.23% decrease, closing at $0.03. Notable gainers included Cann Gr, Khiron Life Sciences, and Canopy Growth, with increases of 125.92%, 59.09%, and 5.22% respectively. Among the losers, Greenlane Holdings and OrganiGram Holdings saw declines of 5.20% and 3.96%. The article was generated by Benzinga's automated content engine.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 9:30 pm

On January 22, 2024, several cannabis-related stocks experienced significant price movements. Notable gainers included Cansortium, Global Hemp Group, and Blueberries Medical, with increases of 27.27%, 25.00%, and 18.18% respectively. Urban-gro, OrganiGram Holdings, and Psychemedics also saw gains on NASDAQ. Conversely, AusCann Group Holdings, EVIO, and Maple Leaf Green World were among the biggest losers, with AusCann's shares plummeting by 59.42%. Corbus Pharmaceuticals and Eastside Distilling also experienced declines on NASDAQ.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 9:30 pm

On January 17, 2024, several cannabis stocks experienced significant price movements. AusCann Group Holdings led the gainers with a 187.50% increase, while MedMen Enterprises and GreenGro Technologies were the biggest losers, both dropping by over 99%. Other notable gainers include Khiron Life Sciences and Maple Leaf Green World, with increases of 54.29% and 32.45%, respectively. Among the losers, 22nd Century Group and OrganiGram Holdings saw declines of 14.72% and 7.89%. The movements reflect the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 10, 2024. Choom Holdings, EVIO, Global Hemp Group, Global Compliance, Cannabix Technologies, Body and Mind, Pharmadrug, Neptune Wellness Solutions, and Trees saw gains, with Choom Holdings leading with a 9900% increase. Conversely, Acacia Diversified Holdings led the losers with a 99% decline, followed by significant losses in Cann Gr, Khiron Life Sciences, CordovaCann, Elixinol Wellness, 1933 Industries, Item 9 Labs, Affinor Growers, 4Front Ventures, C21 Investments, Heritage Cannabis Holding, Cresco Labs, Leafbuyer Techs, Trulieve Cannabis, Eastside Distilling, Curaleaf Holdings, Cara Therapeutics, Indiva, Auxly Cannabis Group, RIV Capital, Tilray Brands, Greenlane Holdings, iAnthus Capital Holdings, Psychemedics, SNDL, and SOL Global Investments.

Portfolio Pulse from Benzinga Insights

January 10, 2024 | 9:30 pm

The marijuana stock market saw significant movements on January 9, 2024, with a mix of gainers and losers. Notable gainers included AusCann Group Holdings, Rocky Mountain High, and Item 9 Labs with substantial percentage increases in their share prices. On the other hand, Australis Capital and Choom Holdings experienced dramatic declines, with Australis Capital shares closing down 100%. Other notable losers included Tilray Brands, Canopy Growth, and SNDL with significant percentage decreases. This market activity reflects the volatile nature of the marijuana industry stocks.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.